Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
ENDPOINTS
editor@endpointsnews.com
author articles
AbbVie’s Rinvoq is approved in giant cell arteritis; Relmada shares bladder cancer data
2 months ago
News Briefing
Biohaven gets an up to $600M investment; Prilenia, Ferrer make a deal in Europe
2 months ago
News Briefing
Lilly asks EU regulator to revisit Kisunla; CHMP recommends PTC's PKU drug
2 months ago
News Briefing
Avidicure's $50M seed round; Flagship's new AI company that detects disease
2 months ago
News Briefing
Veraxa makes a SPAC deal; Illumina discloses layoffs
2 months ago
News Briefing
Danaher expects about $350M in tariff costs; Alumis, Acelyrin adjust deal terms
2 months ago
News Briefing
Novartis terminates knee pain study; Telix reports brain tumor data
2 months ago
News Briefing
Boehringer's bispecific pact with Cue Biopharma; HepaRegeniX raises €21.5M
2 months ago
News Briefing
Argenx’s Vyvgart Hytrulo syringe is approved in the US; Opthea to cut 65% of staff
3 months ago
News Briefing
Idorsia’s blood pressure pill no longer requires a REMS; Solu raises $41M
3 months ago
News Briefing
Rallybio ends development in rare disorder; ImmunityBio raises $75M
3 months ago
News Briefing
Lexeo discloses new data for heart drug; Spark Therapeutics to lay off workers
3 months ago
News Briefing
Sarepta indicates it's safe to continue Elevidys dosing in Europe; Epsilogen buys TigaTx
3 months ago
News Briefing
Roche says Ocrevus failed Phase 3 study; Sanofi licenses autoimmune asset from Nurix
3 months ago
News Briefing
Prazer Therapeutics raises $20M; Carisma lets go of most staff
3 months ago
News Briefing
LifeMine’s restructuring; Europe won’t renew authorization for PTC’s Duchenne drug
3 months ago
News Briefing
DBV’s financing for peanut allergy patch; Eisai divests proton pump inhibitor in China
3 months ago
News Briefing
Nkarta to lay off 34% of staff; Savara’s debt financing deal
3 months ago
News Briefing
Humacyte to raise $50M; Acrivon to focus on prexasertib in endometrial cancer
3 months ago
News Briefing
Cassava ends work on Alzheimer's drug; Alumis gets $40M upfront from Kaken
3 months ago
News Briefing
Surrozen raises $175M, to focus on ophthalmology; CBC Group has a new $1B fund
3 months ago
News Briefing
Genfit's up to €185M royalty deal; J&J’s Tremfya gets a Crohn's approval
3 months ago
News Briefing
BridgeBio, Editas finance chiefs depart; Former FDA No. 2 joins Recursion's board
3 months ago
Peer Review
Elevation Oncology stops work on ADC, lays off workers; AstraZeneca’s CEPI funding
3 months ago
News Briefing
First page
Previous page
1
2
3
4
5
6
Next page
Last page